Hands-on Workshops as An Effective Means of Learning Advanced Technologies Including Genomics, Proteomics and Bioinformatics

Genomics, Proteomics and Bioinformatics

Volumn 11, Issue 6, 2013, Pages 368-377

  Reisdorph, Nichole ^a   Stearman, Robert ^b   Kechris, Katerina ^c   Phang, Tzu Lip ^b   Reisdorph, Richard ^a   Prenni, Jessica ^d   Erle, David J ^e   Coldren, Christopher ^b,h   Schey, Kevin ^f   Nesvizhskii, Alexey ^g   Geraci, Mark ^b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Global Health and Health Disparities   (United States)

^d Department of Environmental and Radiological Health Sciences   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h Bioinformatics Pathgroup   (United States)

Author keywords

Bioinformatics; Genomics; Hands on; Mass spectrometry; Proteomics; Workshops

Indexed keywords

ADVERTIZING; ARTICLE; BIOINFORMATICS; COMPUTER PROGRAM; COURSE CONTENT; COURSE EVALUATION; CURRICULUM; EDUCATION PROGRAM; EQUIPMENT; EVALUATION STUDY; GENOMICS; HUMAN; HUMAN EXPERIMENT; INSTITUTIONAL REVIEW; INTERNET; LEARNING; MASS SPECTROMETRY; NORMAL HUMAN; OUTCOME OF EDUCATION; PERSONAL EXPERIENCE; PROTEOMICS; SCIENTIST; WORKSHOP;

BIOINFORMATICS; GENOMICS; HANDS-ON; MASS SPECTROMETRY; PROTEOMICS; WORKSHOPS;

BIOMEDICAL RESEARCH; COMPUTATIONAL BIOLOGY; CURRICULUM; EDUCATION; HUMANS; SOFTWARE;

EID: 84891134073     PISSN: 16720229     EISSN: 22103244     Source Type: Journal    
DOI: 10.1016/j.gpb.2013.10.002     Document Type: Article

References (38)

1. Chadwell K. Clinical practice on the horizon: personalized medicine. Clin Nurse Spec 2013, 27:36-43.
2. Venegas M., Brahm J., Villanueva R.A. Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment. Ann Hepatol 2012, 11:827-837.
3. Dandona S., Roberts R. Personalized cardiovascular medicine: status in 2012. Can J Cardiol 2012, 28:693-699.
4. Miller D.B., O'Callaghan J.P. Personalized medicine in major depressive disorder - opportunities and pitfalls. Metabolism 2013, 62:S34-S39.
5. Gonzalez de Castro D., Clarke P.A., Al-Lazikani B., Workman P. Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance. Clin Pharmacol Ther 2013, 93:252-259.
6. Baker E.S., Liu T., Petyuk V.A., Burnum-Johnson K.E., Ibrahim Y.M., Anderson G.A., et al. Mass spectrometry for translational proteomics: progress and clinical implications. Genome Med 2012, 4:63.
7. Chung L., Baxter R.C. Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays. Expert Rev Proteomics 2012, 9:599-614.
8. Indovina P., Marcelli E., Pentimalli F., Tanganelli P., Tarro G., Giordano A. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery. Mass Spectrom Rev 2013, 32:129-142.
9. Lin J.L., Bonnichsen M.H., Nogeh E.U., Raftery M.J., Thomas P.S. Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Expert Rev Proteomics 2010, 7:361-372.
10. McDonnell L.A., Corthals G.L., Willems S.M., van Remoortere A., van Zeijl R.J., Deelder A.M. Peptide and protein imaging mass spectrometry in cancer research. J Proteomics 2010, 10:1921-1944.
11. Ozben T. Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry. Clin Chem Lab Med 2013, 51:157-176.
12. Sharma N., Martin A., McCabe C.J. Mining the proteome: the application of tandem mass spectrometry to endocrine cancer research. Endocr Relat Cancer 2012, 19:R149-R161.
13. Participants NCFW Metabolomics and translational research videoconference April 6, 2011, NIH Common Fund, Bethesda, MD, Available from: .
14. Baggerly K. Disclose all data in publications. Nature 2010, 467:401.
15. Baggerly K.A., Coombes K.R. What information should be required to support clinical "omics" publicationsα. Clin Chem 2011, 57:688-690.
16. Leek J.T., Scharpf R.B., Bravo H.C., Simcha D., Langmead B., Johnson W.E., et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet 2010, 11:733-739.
17. Orchard S., Binz P.A., Borchers C., Gilson M.K., Jones A.R., Nicola G., et al. Ten years of standardizing proteomic data: a report on the HUPO-PSI Spring workshop: April 12-14th, 2012, San Diego, USA. Proteomics 2012, 12:2767-2772.
18. Armstrong M., Jonscher K., Reisdorph N.A. Analysis of 25 underivatized amino acids in human plasma using ion-pairing reversed-phase liquid chromatography/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2007, 21:2717-2726.
19. Bowler R., Reisdorph N. Mining the liver proteome for drug targets for sepsis. Crit Care Med 2007, 35:2443-2444.
20. Chu H.W., Gally F., Thaikoottathil J., Janssen-Heininger Y.M., Wu Q., Zhang G., et al. SPLUNC1 regulation in airway epithelial cells: role of Toll-like receptor 2 signaling. Respir Res 2010, 11:155.
21. + T cells. Diabetes 2011, 60:2325-2330.
22. Munks M.W., McKee A.S., Macleod M.K., Powell R.L., Degen J.L., Reisdorph N.A., et al. Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo. Blood 2010, 116:5191-5199.
23. 4 levels identify children with tobacco smoke exposure at risk for asthma exacerbation. J Allergy Clin Immunol 2011, 128:323-327.
24. Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010, 11:225-231.
25. 4 in human urine: comparison of on-line purification and liquid chromatography-tandem mass spectrometry to affinity purification followed by enzyme immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:3169-3174.
26. Bennett B., Saba L.M., Hornbaker C.K., Kechris K.J., Hoffman P., Tabakoff B. Genetical genomic analysis of complex phenotypes using the PhenoGen website. Behav Genet 2011, 41:625-628.
27. Fujimoto S., Seebart C., Guastafierro T., Prenni J., Caiafa P., Zlatanova J. Proteome analysis of protein partners to nucleosomes containing canonical H2A or the variant histones H2A.Z or H2A.X. Biol Chem 2012, 393:47-61.
28. Goldstrohm D.A., Broeckling C.D., Prenni J.E., Curthoys N.P. Importance of manual validation for the identification of phosphopeptides using a linear ion trap mass spectrometer. J Biomol Tech 2011, 22:10-20.
29. Hoffman P.L., Bennett B., Saba L.M., Bhave S.V., Carosone-Link P.J., Hornbaker C.K., et al. Using the phenogen website for 'in silico' analysis of morphine-induced analgesia: identifying candidate genes. Addict Biol 2011, 16:393-404.
30. Kechris K.J., Biehs B., Kornberg T.B. Generalizing moving averages for tiling arrays using combined p-value statistics. Stat Appl Genet Mol Biol 2010, 9. Article 29.
31. Kruh N.A., Troudt J., Izzo A., Prenni J., Dobos K.M. Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo. PLoS One 2010, 5:e13938.
32. Mehaffy C., Hess A., Prenni J.E., Mathema B., Kreiswirth B., Dobos K.M. Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis. Proteomics 2010, 10:1966-1984.
33. Mueller N.H., Walters M.S., Marcus R.A., Graf L.L., Prenni J., Gilden D., et al. Identification of phosphorylated residues on varicella-zoster virus immediate-early protein ORF63. J Gen Virol 2010, 91:1133-1137.
34. Pollock D.D., de Koning A.P., Kim H., Castoe T.A., Churchill M.E., Kechris K.J. Bayesian analysis of high-throughput quantitative measurement of protein-DNA interactions. PLoS One 2011, 6:e26105.
35. Ryan E.P., Heuberger A.L., Weir T.L., Barnett B., Broeckling C.D., Prenni J.E. Rice bran fermented with Saccharomyces boulardii generates novel metabolite profiles with bioactivity. J Agric Food Chem 2011, 59:1862-1870.
36. Saba L.M., Bennett B., Hoffman P.L., Barcomb K., Ishii T., Kechris K., et al. A systems genetic analysis of alcohol drinking by mice, rats and men: influence of brain GABAergic transmission. Neuropharmacology 2011, 60:1269-1280.
37. 1H-NMR-based metabolomics. Expert Rev Mol Diagn 2006, 6:717-731.
38. Serkova N.J., Standiford T.J., Stringer K.A. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med 2011, 184:647-655.